IL138562A0 - Method for sterilising native collagen is liquid medium, resulting native collagen, compositions containing same and uses - Google Patents

Method for sterilising native collagen is liquid medium, resulting native collagen, compositions containing same and uses

Info

Publication number
IL138562A0
IL138562A0 IL13856299A IL13856299A IL138562A0 IL 138562 A0 IL138562 A0 IL 138562A0 IL 13856299 A IL13856299 A IL 13856299A IL 13856299 A IL13856299 A IL 13856299A IL 138562 A0 IL138562 A0 IL 138562A0
Authority
IL
Israel
Prior art keywords
collagen
native collagen
sterilising
liquid medium
compositions containing
Prior art date
Application number
IL13856299A
Other languages
English (en)
Original Assignee
Octapharma Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Octapharma Ag filed Critical Octapharma Ag
Publication of IL138562A0 publication Critical patent/IL138562A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/78—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin or cold insoluble globulin [CIG]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/22—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons containing macromolecular materials
    • A61L15/32—Proteins, polypeptides; Degradation products or derivatives thereof, e.g. albumin, collagen, fibrin, gelatin
    • A61L15/325—Collagen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2/00—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor
    • A61L2/0005—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor for pharmaceuticals, biologicals or living parts
    • A61L2/0011—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor for pharmaceuticals, biologicals or living parts using physical methods
    • A61L2/0017—Filtration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2/00—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor
    • A61L2/0005—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor for pharmaceuticals, biologicals or living parts
    • A61L2/0082—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor for pharmaceuticals, biologicals or living parts using chemical substances
    • A61L2/0088—Liquid substances
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
    • A61L26/0009—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form containing macromolecular materials
    • A61L26/0028—Polypeptides; Proteins; Degradation products thereof
    • A61L26/0033—Collagen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
    • A61L26/0009—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form containing macromolecular materials
    • A61L26/0052—Mixtures of macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
    • A61L31/04—Macromolecular materials
    • A61L31/043—Proteins; Polypeptides; Degradation products thereof
    • A61L31/044—Collagen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Materials Engineering (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Toxicology (AREA)
  • Biochemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Genetics & Genomics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Hematology (AREA)
  • Biophysics (AREA)
  • Surgery (AREA)
  • Cardiology (AREA)
  • Diabetes (AREA)
  • Vascular Medicine (AREA)
  • Cosmetics (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Peptides Or Proteins (AREA)
  • Materials For Medical Uses (AREA)
  • Food Preservation Except Freezing, Refrigeration, And Drying (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Distillation Of Fermentation Liquor, Processing Of Alcohols, Vinegar And Beer (AREA)
IL13856299A 1998-04-10 1999-04-09 Method for sterilising native collagen is liquid medium, resulting native collagen, compositions containing same and uses IL138562A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9804531A FR2777284B1 (fr) 1998-04-10 1998-04-10 Procede de sterilisation d'un collagene natif en milieu liquide, collagene natif sterile obtenu, compositions le contenant et applications
PCT/FR1999/000814 WO1999052946A1 (fr) 1998-04-10 1999-04-09 Procede de sterilisation d'un collagene natif en milieu liquide, collagene natif sterile obtenu, compositions le contenant et applications

Publications (1)

Publication Number Publication Date
IL138562A0 true IL138562A0 (en) 2001-10-31

Family

ID=9525129

Family Applications (1)

Application Number Title Priority Date Filing Date
IL13856299A IL138562A0 (en) 1998-04-10 1999-04-09 Method for sterilising native collagen is liquid medium, resulting native collagen, compositions containing same and uses

Country Status (20)

Country Link
EP (1) EP1068240B1 (ko)
JP (1) JP2002511489A (ko)
KR (1) KR20010042539A (ko)
CN (1) CN1304416A (ko)
AT (1) ATE229982T1 (ko)
AU (1) AU3151499A (ko)
BR (1) BR9909566A (ko)
CA (1) CA2327882A1 (ko)
DE (1) DE69904578T2 (ko)
EE (1) EE200000592A (ko)
FR (1) FR2777284B1 (ko)
HU (1) HUP0102575A2 (ko)
ID (1) ID26038A (ko)
IL (1) IL138562A0 (ko)
NO (1) NO20005079L (ko)
PL (1) PL343523A1 (ko)
RU (1) RU2188206C2 (ko)
WO (1) WO1999052946A1 (ko)
YU (1) YU61100A (ko)
ZA (1) ZA200005497B (ko)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7816492B2 (en) 1998-11-20 2010-10-19 Arena Pharmaceuticals, Inc. Human G protein-coupled receptors
US20030017528A1 (en) 1998-11-20 2003-01-23 Ruoping Chen Human orphan G protein-coupled receptors
USRE42190E1 (en) 1998-11-20 2011-03-01 Arena Pharmaceuticals, Inc. Method of identifying a compound for inhibiting or stimulating human G protein-coupled receptors
AT411326B (de) * 2000-06-20 2003-12-29 Biering Wolfgang Hämostatische collagen-pellets
JP4705359B2 (ja) * 2004-10-20 2011-06-22 新田ゼラチン株式会社 鳥類由来コラーゲンを用いてなる化粧料組成物
DE102005017845A1 (de) * 2005-04-18 2006-10-19 Lohmann & Rauscher Gmbh & Co. Kg Autosterile, antiseptische Kollagenzubereitungen, ihre Verwendung und Verfahren zu ihrer Herstellung
CN101332316B (zh) * 2008-07-22 2012-12-26 广东冠昊生物科技股份有限公司 生物型鼻梁植入体
US20080102095A1 (en) * 2006-10-31 2008-05-01 Kent Young Acidic processes to prepare antimicrobial contact lenses
KR101629517B1 (ko) * 2007-06-01 2016-06-13 교와 핫꼬 바이오 가부시키가이샤 경구 조성물
DK3243489T3 (da) * 2011-05-24 2021-05-10 Takeda As Oprullet kollagenbærer
JP6242873B2 (ja) 2012-05-24 2017-12-06 タケダ エイエスＴａｋｅｄａ ＡＳ コイル状コラーゲンキャリアを提供する装置およびプロセス
BR112014028836B1 (pt) 2012-05-24 2021-06-29 Takeda As Embalagem para armazenar um portador de colágeno em espiral com forma estável
CN102846536B (zh) * 2012-09-26 2014-03-26 关节动力安达（天津）生物科技有限公司 一种含有i型胶原蛋白的精华液
RU2597085C2 (ru) * 2013-11-07 2016-09-10 Федеральное государственное бюджетное учреждение науки Институт биологии моря им. А.В. Жирмунского Дальневосточного отделения Российской академии наук (ИБМ ДВО РАН) Имплантируемый матриксный материал для регенеративной медицины и способ его получения (варианты)
JP6967210B2 (ja) * 2018-04-27 2021-11-17 凸版印刷株式会社 細胞外マトリックス含有組成物、三次元組織体形成用仮足場材及び三次元組織体形成剤並びに三次元組織体から細胞を回収する方法
RU2715715C1 (ru) * 2019-03-06 2020-03-03 Общество с ограниченной ответственностью фирмы "Имтек" Стерильный прозрачный концентрированный раствор биосовместимого коллагена, способ его получения и применения
CN110354246A (zh) * 2019-07-22 2019-10-22 中肽生物科技(大连)有限公司 一种纳米级小分子复合肽养眼液的制备方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2462222A1 (de) * 1974-02-02 1976-05-06 Trommsdorff Fa H Loesliches, natives human-kollagen, dessen nicht-helikale peptide teilweise oder vollstaendig abgetrennt sind
US3949073A (en) * 1974-11-18 1976-04-06 The Board Of Trustees Of Leland Stanford Junior University Process for augmenting connective mammalian tissue with in situ polymerizable native collagen solution
DE3522626A1 (de) * 1985-06-25 1987-01-08 Merz & Co Gmbh & Co Loeslicher kollagen-schwamm
FR2586703B1 (fr) * 1985-09-02 1989-12-01 Merieux Inst Procede d'extraction de collagenes placentaires, collagenes obtenus notamment sous forme de gels ou de solutions et leurs applications
IT1181737B (it) * 1985-11-26 1987-09-30 Pierfrancesco Morganti Supproto di collagene biologicamente attivo per uso cosmetico e farmaceutico e metodo per prepararlo
FR2715309B1 (fr) * 1994-01-24 1996-08-02 Imedex Composition adhésive, à usage chirurgical, à base de collagène modifié par coupure oxydative et non réticulé.
CA2146090C (en) * 1994-05-10 1998-11-24 Mark E. Mitchell Apparatus and method of mixing materials in a sterile environment
US5670369A (en) * 1996-06-25 1997-09-23 Ranpak Corporation Method for the production of soluble collagen

Also Published As

Publication number Publication date
NO20005079D0 (no) 2000-10-09
EE200000592A (et) 2002-04-15
RU2188206C2 (ru) 2002-08-27
NO20005079L (no) 2000-12-08
EP1068240B1 (fr) 2002-12-18
JP2002511489A (ja) 2002-04-16
FR2777284B1 (fr) 2000-05-26
WO1999052946A1 (fr) 1999-10-21
EP1068240A1 (fr) 2001-01-17
BR9909566A (pt) 2000-12-26
KR20010042539A (ko) 2001-05-25
YU61100A (sh) 2003-10-31
AU3151499A (en) 1999-11-01
ID26038A (id) 2000-11-16
ATE229982T1 (de) 2003-01-15
PL343523A1 (en) 2001-08-27
DE69904578T2 (de) 2003-11-20
DE69904578D1 (de) 2003-01-30
CN1304416A (zh) 2001-07-18
ZA200005497B (en) 2001-04-24
CA2327882A1 (en) 1999-10-21
FR2777284A1 (fr) 1999-10-15
HUP0102575A2 (hu) 2001-11-28

Similar Documents

Publication Publication Date Title
IL138562A0 (en) Method for sterilising native collagen is liquid medium, resulting native collagen, compositions containing same and uses
CA2146938A1 (en) Method of Controlling Structure Stability of Collagen Fibers Produced from Solutions or Dispersions Treated with Sodium Hydroxide for Infectious Agent Deactivation
DK0760651T3 (da) Farmaceutiske præparater stammende fra mikroemulsion-baserede geler, fremgangsmåde til fremstilling deraf samt nye mikroemulsion-baserede geler
CA2247860A1 (en) Method for treating liquid materials
NZ509563A (en) Functional soy food ingredient
CA2148583A1 (en) Viscoelastic Surfactant Based Foam Fluids
DE69919154D1 (de) Hydrokolloidzusammensetzung zur verwendung als geliermittel, verdickungsmittel und stabilisator
ES2032121T3 (es) Particulas de emulsion gelificadas y composiciones que las contienen.
DE69710879D1 (de) Arzneimittel auf basis von progesteron und östradiol
GB2354167A (en) Gel cosmetic compositions
WO1999049881A3 (de) Verwendung von hsp70 protein
AU2003285327A1 (en) Cosmetic dressings containing a waxy component, a film-forming agent and a gel-forming substance
DE69120287D1 (en) Aminosulfonylharnstoff-acat-inhibitoren
MX9706981A (es) Conformacion de construccion de zapato y composiciones de gel para la misma.
AU2623895A (en) Dialysis fluid containing peptides obtained from casein as osmotic agents and bicarbonate ions as buffering agents
FR2791559B1 (fr) Composition cosmetique comprenant au moins une phase pulverulente, un hydratant et un derive de galactomannane et utilisations
TW377281B (en) Conforming shoe construction and gel compositions therefor
BR0008386A (pt) Dispositivo de aplicação de um produto fluido ou geleificado para o barbear
Johnston High pressure-A new dimension to food processing
DE69426765D1 (de) Zusammensetzung zur Viskositätskontrolle von flüssigen Nährmitteln
MY124594A (en) Method of manufacturing an aseptic coagulated food product
ATE312906T1 (de) Verfahren zur herstellung von sofort-agarmedium
Yamamoto et al. Inhibitory Effect of Lead on the Release of Tissue Plasminogen Activator from Human Vascular Endothelial Cells in Culture (Proceedings of the 18th Symposium on Toxicology, and Environmental Health)
DE59906433D1 (en) Kontrasmittel auf basis polyoxyethylen-660-12-hydroxystearat und anionische phospholipide
Tsuji et al. An Application of Fuzzy System to Orthodontic Diagnosis in Orthosurgical Case